MedPath

Establishment Labs

Ownership
-
Employees
908
Market Cap
-
Website
Introduction

Establishment Labs Holdings, Inc. is a technology company, which engages in the design, development, manufacture, and marketing of silicone breast implants. It generates income from customers in Europe, the Middle East, Latin America, and Asia. The firm's products include Motiva Implants, Motiva Flora Tissue Expander, Motiva Ergonomix, and Motiva Ergonomix2. The company was founded by Juan Jose Chacon-Quiros in 2004 and is headquartered in Alajuela, Costa Rica.

Clinical Trials

6

Active:0
Completed:3

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Mia® Clinical Study

Not Applicable
Completed
Conditions
Breast Augmentation
First Posted Date
2025-01-24
Last Posted Date
2025-01-24
Lead Sponsor
Establishment Labs
Target Recruit Count
100
Registration Number
NCT06792409
Locations
🇨🇷

Centro Europeo de Cirugía, San José, Costa Rica

Safety and Performance of Motiva® Sizers

Recruiting
Conditions
Breast Augmentation
Breast Implantation; Methods, Safety and Performance
Mammaplasty
Breast Reconstruction
Breast Implant; Complications
First Posted Date
2024-02-23
Last Posted Date
2024-02-23
Lead Sponsor
Establishment Labs
Target Recruit Count
330
Registration Number
NCT06274736
Locations
🇨🇷

Establishment Labs, Coyol, Alajuela, Costa Rica

Motiva Flora® Aesthetic Breast Recon® Clinical Study

Not Applicable
Recruiting
Conditions
Breast Cancer
Mammaplasty
Poland Syndrome
First Posted Date
2023-11-24
Last Posted Date
2023-12-05
Lead Sponsor
Establishment Labs
Target Recruit Count
66
Registration Number
NCT06146231
Locations
🇧🇪

Universitair Ziekenhuis Gent, Ghent, Belgium

🇨🇴

Hospital Universitario San Ignacio, Bogotá, Colombia

🇨🇷

Hospital UNIBE, San José, Costa Rica

and more 1 locations

Retrospective Data Collection on the Use of Motiva Flora TE in Breast Reconstruction

Completed
Conditions
Breast Cancer
First Posted Date
2022-07-14
Last Posted Date
2024-08-27
Lead Sponsor
Establishment Labs
Target Recruit Count
144
Registration Number
NCT05459064
Locations
🇧🇪

Dr Filip Stillaert, Ghent, Belgium

🇪🇸

Fundacion Tejerina, Madrid, Spain

Motiva Flora Tissue Expander PMCF

Not Applicable
Recruiting
Conditions
Breast Tissue Accessory
Breast Cancer
First Posted Date
2022-07-07
Last Posted Date
2024-08-27
Lead Sponsor
Establishment Labs
Target Recruit Count
136
Registration Number
NCT05447988
Locations
🇨🇱

Centro de Cirugía Plástica y Reconstructiva. Dra. Viviana Spröhnle Hospital Regional de Rancagua, Rancagua, Chile

🇨🇷

Centro Europeo de Cirugia, San José, San Jose, Costa Rica

🇵🇦

The Panama Clinic Complejo Hospitalario Pacific Center, Panama, Panama

and more 2 locations

News

Establishment Labs Gains FDA Approval for Motiva Breast Implants

Establishment Labs has received FDA approval for its Motiva SmoothSilk Ergonomix and Round breast implants for primary and revision augmentation.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.